Browse the corpus

Constipation, a prevalent condition affecting both children and adults, poses significant challenges if left unmanaged, potentially leading to complications like fecal impaction. With constipation ranking high among outpatient gastrointestinal (GI) diagnoses clinicians must navigate a diverse array of pharmacologic options, including over-the-counter laxatives in various formulations such as bulking agents, stool softeners, stimulant laxatives like bisacodyl, and osmotic laxatives. To optimize patient outcomes and enhance their quality of life, clinicians should engage in thorough discussions with patients, coordinate closely with nurses or caregivers, and carefully weigh the risks and benefits of laxative use, particularly bisacodyl, which demands attention due to its potential adverse effects. This activity reviews the necessary education for best practice use of biscodyl, particularly in cases where laxative misuse is intertwined with complex psychiatric disorders like bulimia or anorexia nervosa, necessitating referral for specialized psychiatric care. Through collaborative efforts encompassing clinicians, pharmacists, gastroenterologists, and nurses, a multidisciplinary approach can effectively mitigate risks associated with bisacodyl and other laxatives when striving for optimal patient outcomes. Objectives: Differentiate between the mechanisms of action of bisacodyl and other laxatives. Apply evidence-based guidelines in selecting bisacodyl for constipation management in clinical practice. Select alternative treatment options if bisacodyl is contraindicated or ineffective. Implement communication among interprofessional team members to improve outcomes and treatment efficacy for patients who might benefit from bisacodyl therapy. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose Overdosing of bisacodyl can induce diarrhea, leading to electrolyte disturbances, including hypokalemia, hypocalcemia, metabolic acidosis, or alkalosis, which may also produce vomiting and muscle weakness. Short-term use (3 days) of the recommended dose does not affect serum electrolytes.[2] A case report of chronic abuse of bisacodyl in a female patient showed a frequent and repetitive formation of urinary calculi with rapid double J stent encrustation.[39] Management of Overdose The management of bisacodyl overdose is supportive, focusing on ensuring adequate hydration and correcting any electrolyte imbalances. Recommendations The treatment of laxative abuse is to cease the causative agent; this is challenging because constipation may occur again after stopping this drug, leading to patient distress.[40] Bisacodyl is not recommended for use for more than 4 weeks due to harmful long-term colonic effects and possible carcinogenic risk of stimulant laxatives. Epidemiological studies investigating its effects and safety over longer terms are warranted.[12]

Constipation is a common disease that affects children and adults, especially older patients. Unmanaged constipation can progress to fecal impaction, which further impairs patients' quality of life and increases healthcare costs. Constipation is one of the most prevalent outpatient diagnoses among GI disorders.[40] Many pharmacologic agents are available for constipation, including over-the-counter (OTC) laxative products, rectal suppositories, and enemas. Oral products can be classified as bulking agents, stool softeners, stimulant laxatives, and osmotic laxatives.[36] Clinicians should assess the risks and benefits of using bisacodyl and individualize treatment based on the patient's symptoms and pathophysiology. Pharmacists must counsel, make recommendations, and contact the treating clinician if necessary. Nurses must take a thorough medication history. Referral to a gastroenterologist may be necessary for refractory cases. This interprofessional team approach ensures optimal patient outcomes. Laxatives are used to relieve symptoms, but some patients may misuse them. Such misuse of laxatives may indicate an underlying medical disorder. Determining what may promote the behavior is the first step in treating laxative misuse. The individual who misuses the laxatives has to stop the stimulant laxatives and replace them with osmotic supplements to establish regular bowel movements. Education and further treatment are required to maintain a healthy bowel program. Referral for psychiatric treatment is essential in the case of eating disorders such as bulimia or anorexia nervosa to lessen the reliance on laxatives as a method to alter perceived weight and shape.[41] Interprofessional collaboration with open communication between clinicians (MDs, DOs, NPs, PAs), pharmacists, gastroenterologists, and nurses can minimize the risk associated with bisacodyl and achieve optimal patient outcomes.